NewsbenzingaJP Morgan Downgrades Fulcrum Therapeutics to UnderweightJun 3, 2026, 11:29 ET · PublishedSummaryOriginalView sourceArticle summaryPlease check the source for details.An excerpt from the original article.Related companiesFULCFULCView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…